PPT-Managing Bleeds in Patients Anticoagulated With Warfarin and Other Agents

Author : danika-pritchard | Published Date : 2018-11-05

IntroductionOverview VKAAssociated Bleeding Results From the RADOA Registry Reversal Agents for VKAAssociated Anticoagulation Management of Urgent Anticoagulation

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Managing Bleeds in Patients Anticoagulat..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Managing Bleeds in Patients Anticoagulated With Warfarin and Other Agents: Transcript

IntroductionOverview VKAAssociated Bleeding Results From the RADOA Registry Reversal Agents for VKAAssociated Anticoagulation Management of Urgent Anticoagulation Reversal 4FPCC vs FFP. Nose Bleeds Epistaxis Nose bleeds are very common, occurring in up to 60% of the general population. In most situations, nose bleeds are simply a nuisance. However, they can be frightening if the bl Northlakes. Community Clinic. Minong, WI. Novel Anticoagulants:. Who Needs an INR Anymore?. Apixaban. (. Eliquis. ):. Approved in 2014. Rivaroxaban. (. Xarelto. ):. Approved in 2011. Dabigatran. (. Dr C E du Toit. Groote . Schuur. Hospital. An inherited, X-linked, lifelong bleeding disorder affecting males almost exclusively. Factor VIII deficiency = Haemophilia A. Factor IX deficiency = Haemophilia B. We Now?. Moderator. Christian T. Ruff, MD, MPH. Assistant Professor of Medicine. TIMI Study Group. Brigham and . Women's . Hospital. Harvard Medical School. Boston, Massachusetts. Arash Afshinnik, MD. Fred V. Plapp MD PhD. Pathology and Laboratory Medicine. Kansas University Medical Center. Financial Disclosure. Educational Objectives. Discuss intracerebral hemorrhage prevalence and etiologies. Review anticoagulation by warfarin and anti-Factor . Advantages of NOACs. No INR monitoring required. No bridging required . Easier to manage around surgical procedures. Convenient for rural patients or those with other barriers to . clinic . visits. Fewer. this area bleeds ALWAYS GVW: 19,500 LBS. BBC: 72” ENGINE MODEL: J05E-UG (HYBRID) 210HP 440 LB-FT TORQUE 2020 HINO195h WWW.HINO.COM TELEMATICS, CASE MANAGEMENT, REMOTE DIAGNOSTICS... STA Indication and Target INRAtrial Fibrillation / Atrial Flutter INR 23 Goal 25Stroke INR 23 Goal 25Mechanical ValveAortic Position INR 23 Goal 2Aortic PositionMitral Position INR 2535 Goal 3 OtherPos Sean O’Brien. ADAS Deputy Manager. Bev . Straker - Bennett Senior Specialist Anticoagulation BMS. August 2019. Service Provision. ADAS is a Consultant . led . service managed by the Pathology . Directorate.. Kourosh. . Sadeghi. Tehran University of medical sciences. New Oral Anticoagulants (NOACs). Available in Iran. NOACs. Clinical Trials. RE-LY Study. 951 . clinical . centers in . 44 . countries, . Non-inferiority trial, 18,113 patients, fixed doses of dabigatran 110 mg or 150 mg twice daily — or, in an un-blinded fashion, adjusted-dose warfarin. . hip fractures. Dr Linda Xu . linda.xu@health.nsw.gov.au. Dr Nichola Boyle . Prof LeCouteur. Concord Repatriation General Hospital, NSW Australia. Background. Hip fracture most costly fracture type based on “per fracture” basis. atrophiclichen sclerosusWhat is the difference between atrophicginitis and lichen sclerosus? What are thetreatments?Atrophic VaginitisAtrophic vaginitis is a thinning of the epitheli-um, usually secon 1 COUMADIN Tablets for oralLactose, starch and magnesium stearate 1 mg: D&C Red No. 6 Barium Lake 2 mg: FD&C Blue No. 2 Aluminum Lake and FD&C Red No. 40 Aluminum Lake 2-1/2 mg: D&C Yellow No. 10 NOAC vs Warfarin Atrial Fibrillation Studies – Asian representation. RE-LY. ROCKET. ARISTOTLE. ENGAGE. Drug. Dabigatran. Rivaroxaban. Apixaban. Edoxaban. Class. DTI. Anti-. Xa. Anti-. Xa. Anti-. Xa.

Download Document

Here is the link to download the presentation.
"Managing Bleeds in Patients Anticoagulated With Warfarin and Other Agents"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.